Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder

  • STATUS
    Recruiting
  • End date
    Apr 1, 2024
  • participants needed
    130
  • sponsor
    SpineX Inc.
Updated on 14 June 2022
stroke
electrical stimulation
spinal cord
nervous
spinal cord disorder
neurogenic bladder
spinal cord injury
disease or disorder
multiple sclerosis
myelopathies
detrusor overactivity

Summary

The purpose of this study is to evaluate the effectiveness and safety of SCONE neuromodulation therapy after 12 weeks of therapy in comparison to inactive sham control in improving symptoms of Neurogenic Lower Urinary Tract Dysfunction

Details
Condition Neurogenic Bladder, Spinal Cord Injuries, Stroke, Multiple Sclerosis
Treatment SCONE
Clinical Study IdentifierNCT05301335
SponsorSpineX Inc.
Last Modified on14 June 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Subject is ≥ 18 and ≤ 70 years old at the time of enrollment/consent
Subject has a diagnosis of NLUTD due to
Chronic, spinal cord injury at C3 to T8 classified as ASIA A-D on the AIS scale OR
Multiple sclerosis; OR
Stroke
Subject has symptoms of urinary urgency (>50% high urge voids) or increased frequency
of micturition/self-catheterization (more than once every 2 hours) or
incontinence between voids or catheterizations (>5/day)
Subject must demonstrate detrusor overactivity (unintentional detrusor contraction > 10 cm H2O) on clinical urodynamic studies
Subject has sterile urine or asymptomatic bacteriuria
Subject's score is > 28 on NBSS survey
Subject is at least one year post initial diagnosis at the time of enrollment (consent)
Subject's medical condition is stable
Subject has adequate social support network to be able to participate in training and assessment sessions for the duration of the study, at the discretion of the Investigator
Subject has been informed of the nature of the study, can understand the requirements of the study, agrees to participate, and has signed the IRB/EC-approved informed consent

Exclusion Criteria

Subject relies on an indwelling catheter (urethral or suprapubic) for bladder drainage
Subject relies on an indwelling catheter (urethral or suprapubic) for bladder drainage
Subject has participated in other transcutaneous or epidural spinal stimulation trials
Subject has congestive heart failure, pulmonary disease necessitating supplemental oxygen use, chronic kidney disease (Stage III or higher), chronic liver disease (Child Pugh class B or C) or poorly controlled diabetes (if diabetic, HbA1c > 8.0 within the preceding 6 months)
Subject has a concurrent neurological disease affecting the central nervous system, other than spinal cord injury or multiple sclerosis or stroke
Subject has an implanted central or peripheral neuromodulator
Subject has symptomatic, clinically significant autonomic dysreflexia attacks (characterized by headache and systolic blood pressure greater than 180 mmHg) more than once a week
Subject is dependent on an electro-magnetic medical implant (e.g., cardiac pacemaker or implanted drug pump), ventilation support, or other external device
Subject has received intravesical botulinum toxin injection within 12 months preceding enrollment
Subject's BMI is > 35\
Subject has history of morphologic bladder outlet obstruction (e.g., due to benign prostatic hyperplasia, urethral stricture and/or bladder neck contracture)
Subject has history of frequent symptomatic urinary tract infections, defined as receiving five or more courses of urinary tract infection-directed antibiotics within 12 months prior to enrollment
For non-catheterizing subjects, post-void residual is > 100 mL measured by bladder ultrasound, bladder scanner, or one-time catheterization at the time of enrollment
For female subjects, history or physical exam consistent with > Stage II pelvic organ prolapse as defined by the International Continence Society
For male subjects older than 55 years of age,13,14 physical exam or medical imaging (e.g., transrectal ultrasound, abdominal/pelvic computed tomography or magnetic resonance imaging) consistent with prostate size > 50 cm
Subjects with significant stress incontinence as defined by > 3 stress incontinence episodes per day, defined as incontinence episodes precipitated by increased intraabdominal pressure (e.g., cough, sneeze, Valsalva maneuvers, transfers, other forms of physical activity), stress incontinence demonstrated on physical exam or abdominal leak point pressure < 100 cm H2O at bladder volume less than 200ml per urodynamics study
Subject is pregnant or trying to become pregnant; or is nursing
Subject has limited life expectancy or co-morbid conditions, social/psychological problems, or cognitive impairments that, in the opinion of the Investigator, will preclude them from participation and completion of study procedures or requirements
Subject has a medical condition or complications related to the use of certain medications that may affect validity of the study as determined by the Investigator
Subject has a medical condition not listed above that may put the subject at risk as determined by the Investigator
Subject is participating in or plans to participate in another research study that may interfere with study endpoints
Subject is known or suspected to be non-compliant; and/or subject is unable or unwilling to comply with study requirements
\-
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note